AZITRA
Azitra is a clinical-stage medical dermatology company that leverages extensive scientific knowledge about the skin microbiome to discover and develop novel products for the treatment of adverse skin conditions and diseases.The Company’s technology platform, developed in collaboration with scientists at Yale University and the Jackson Laboratory, is based on a proprietary strain of the natural commensal bacteria Staphylococcus epidermidis.
AZITRA
Industry:
Alternative Medicine Biotechnology Consumer Goods Health Care
Founded:
2014-01-01
Address:
Branford, Connecticut, United States
Country:
United States
Website Url:
http://www.azitrainc.com
Total Employee:
1+
Status:
Active
Contact:
(203)599-0700
Email Addresses:
[email protected]
Total Funding:
52.84 M USD
Technology used in webpage:
Domain Not Resolving HSTS IPv6 U.S. Server Location GoDaddy SSL Invalid Certificate Dates Accelerated Mobile Pages Akamai Hosted Comcast
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
LucasPye BIO
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
Nivalis Therapeutics
Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Vera Therapeutics
Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Connecticut Innovations
Connecticut Innovations investment in Series B - Azitra
Bios Partners
Bios Partners investment in Series B - Azitra
Leaps by Bayer
Leaps by Bayer investment in Series B - Azitra
Godfrey Capital
Godfrey Capital investment in Series A - Azitra
KdT Ventures
KdT Ventures investment in Series A - Azitra
Connecticut Innovations
Connecticut Innovations investment in Series A - Azitra
Bios Partners
Bios Partners investment in Series A - Azitra
National Science Foundation
National Science Foundation investment in Grant - Azitra
Sahsen Ventures
Sahsen Ventures investment in Venture Round - Azitra
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Azitra
Key Employee Changes
| Date | New article |
|---|---|
| 2023-07-11 | Azitra appoints co-founder Travis Whitfill as chief operating officer |
| 2021-05-06 | Azitra Appoints Francisco Salva as Chief Executive Officer |
Official Site Inspections
http://www.azitrainc.com Semrush global rank: 13.52 M Semrush visits lastest month: 77
- Host name: 151.101.66.159
- IP address: 151.101.66.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Azitra"
Azitra - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number (203)599-0700 Azitra is a clinical-stage medical dermatology company that leverages extensive scientific knowledge about the skin microbiome to discover and develop novel products …See details»
Azitra, Inc. (AZTR) Company Profile & Overview - Stock Analysis
Jun 16, 2023 Ticker Symbol: AZTR: Exchange: NYSEAMERICAN: Fiscal Year: January - December: Reporting Currency: USD: IPO Price: $5.00: CIK Code: 0001701478: CUSIP …See details»
Azitra, Inc. (AZTR) Company Profile & Facts - Yahoo Finance
See the company profile for Azitra, Inc. (AZTR) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives …See details»
Azitra Inc - LinkedIn
Azitra, Inc. is a preclinical stage biotechnology company harnessing the power of the microbiome to treat skin disease. The Company was founded in 2014 by scientists from Yale University and works ...See details»
Investor FAQs - Azitra, Inc.
For our latest news releases and financial reports, visit our website at ir.azitrainc.com. Press space to expand and collapse this section How can I view documents [Company Name] has …See details»
Azitra, Inc. Appoints Travis Whitfill as Chief Operating Officer
BRANFORD, Conn., July 11, 2023 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for …See details»
Azitra, Inc. (AZTR) Stock Price, Quote & News - Stock …
Nov 22, 2024 Website https://azitrainc.com. Full Company Profile. Financial Performance. In 2023, Azitra's revenue was $686,000, an increase of 141.55% compared to the previous year's $284,000. Losses were -$12.64 million, …See details»
Azitra - BioCT
Azitra, Inc. is a preclinical stage biotechnology company combining the power of the microbiome with cutting-edge genetic engineering to treat skin disease. The Company was...See details»
Azitra, Inc. Announces Pricing of Initial Public Offering | Azitra, Inc.
BRANFORD, Conn., June 15, 2023 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR) (the "Company"), a biopharmaceutical company focused on developing innovative therapies for …See details»
Azitra Company Profile - Office Locations, Competitors, Revenue
Aug 30, 2024 Azitra has 1 employees at their 1 location and $686 k in annual revenue in FY 2023. See insights on Azitra including office locations, competitors, revenue, financials, …See details»
Azitra, Inc. Announces Q1 2024 Financial Results and Provides …
BRANFORD, Conn., May 09, 2024--Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision …See details»
Azitra, Inc. Announces Full Year 2023 Financial Results and
Mar 15, 2024 Azitra, Inc., a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today reported financial results for the full year …See details»
Release Details - ir.azitrainc.com
Sep 30, 2024 BRANFORD, Conn. , Nov. 12, 2024 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative …See details»
Pipeline - Azitra
Targeted cancer therapies have produced significant treatment advances for patients diagnosed with a variety of tumor types, but they are also associated with unique dermatologic toxicities …See details»
Azitra, Inc. Announces Third Quarter 2023 Financial Results and ...
Nov 14, 2023 BRANFORD, Conn.--(BUSINESS WIRE)--Nov. 14, 2023-- Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing …See details»
Azitra, Inc. Announces Third Quarter 2023 Financial Results and ...
Nov 14, 2023 Condensed Consolidated Statement of Operations (Unaudited) Three months Ended September 30, 2023 2022 Service revenue – related partySee details»
Azitra, Inc. Announces New Preclinical Data to be Presented at the ...
Apr 22, 2024 Azitra will present two oral presentations at ASGCT (American Society of Gene and Cell Therapy) Baltimore, MD, May 7-11, 2024 related to ATR-12, Azitra’s candidate for …See details»
Release Details - Azitra, Inc.
Mar 31, 2024 BRANFORD, Conn.--(BUSINESS WIRE)--May 9, 2024-- Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing …See details»
Release Details - Azitra, Inc.
Aug 12, 2024 BRANFORD, Conn.--(BUSINESS WIRE)--Aug. 12, 2024-- Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing …See details»